GILD Gilead Sciences Inc

•    Estee Lauder Companies, Inc.’s (NYSE:EL) second quarter 2012 quarterly earnings increased 17% year over year to $1.00 per share, but missed the Zacks Consensus Estimate of $1.01 by a penny

•    After concerns arose that Idenix Pharmaceuticals, Inc.’s (Nasdaq:IDIX) hepatitis C drug would be unable  to compete with Gilead Sciences, Inc. (Nasdaq:GILD) drug, shares of Idenix declined by 11.5%

•    Genworth Financial Inc’s (NYSE:GNW) fourth quarter operating income came in at $0.17 per share, in line with the Zacks Consensus Estimate

•    Sony Corporation (NYSE:SNE) reported that it has laid off 100 employees over the past few weeks
 

 
ESTEE LAUDER (EL): Free Stock Analysis Report
 
GILEAD SCIENCES (GILD): Free Stock Analysis Report
 
GENWORTH FINL (GNW): Free Stock Analysis Report
 
IDENIX PHARMA (IDIX): Free Stock Analysis Report
 
SONY CORP ADR (SNE): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research